PMID: 7035308Jan 1, 1981Paper

Diagnosis and treatment of the immune hemolytic anemias

Haematologia
R E Rosenfield, S H Diamond

Abstract

Immune hemolytic anemia can be treated by blood transfusion, steroids, cytotoxic drugs, plasmapheresis, and splenectomy. However, the benefits of therapy are dependent upon the relationship of treatment to the etiology of disease. Thus, effective therapy requires sufficient diagnostic precision to distinguish between allogeneic and autologous antibodies, recognize the etiologic role of immunogenic drugs, and define the immunoglobulin classes of both cold and warm reactive autoantibodies along with their complement interactions.

Related Concepts

Related Feeds

Autoimmune Hemolytic Anemia

Autoimmune hemolytic anemia (AIHA) occurs when antibodies directed against the person's own red blood cells (RBCs) cause them to burst (lyse), leading to an insufficient number of oxygen-carrying red blood cells in the circulation. Discover the latest research on AIHA here.

Related Papers

Modern Treatment
W F Rosse, G L Logue
Monatsschrift Kinderheilkunde : Organ der Deutschen Gesellschaft für Kinderheilkunde
K Fischer
Annals of Clinical and Laboratory Science
W R Best
© 2021 Meta ULC. All rights reserved